Original language | English |
---|---|
Article number | CT223 |
Journal | Cancer Research |
Volume | 79 |
Issue number | 13 Suppl. |
DOIs | |
Publication status | Published - Jul 2019 |
Event | Annual Meeting of the American Association for Cancer Research (AACR) 2019 - Atlanta, United States Duration: 29 Mar 2019 → 3 Apr 2019 |
Survival Prolongation by Rationale INnovative Genomics (SPRING): An international WIN Consortium Phase I/II proof-of-concept study to explore the safety and efficacy of a tri-therapy approach using avelumab, palbociclib and axitinib in advanced/metastatic non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates
Benjamin Solomon, Enriqueta Felip, Jair Bar, Guy Berchem, Lyudmila Bazhenova, Pierre Saintigny, Nicolas Girard, Raed Sulaiman, Catherine Bresson, Fanny Wunder, J. Jack Lee, Jacques Raynaud, Eitan Rubin, Brandon Young, Vladimir Lazar, Amir Onn, Brian Leyland Jones, Razelle Kurzrock
Research output: Contribution to journal › Meeting Abstract › peer-review